The outgoing president of the ABPI says UK pharma is negotiating ‘choppy seas’ during Brexit, the new head of the ABPI is announced, IG.com take a look at top 10 healthcare stocks, and England opens new NHS ‘front door’ to health innovators. Read more -
Interested in Star’s innovative outsourcing and resourcing solutions?
Contact Head of Business Development, Ryan Wooller, at firstname.lastname@example.org, or get in touch on 07748 464 079.
On the hunt for a new role, or just curious?
Visit our candidate page, submit your CV to email@example.com, or give our offices a ring!
UK pharma is plotting its way through the chaos of Brexit, while creating a vision for the future of the country’s life sciences industry sector with its new pricing deal for branded drugs.
Haseeb Ahmad, Managing Director, UK, Ireland & Nordics Novartis Pharmaceuticals and Country President Novartis UK has been confirmed as the new President of the ABPI.
The UK has far lower import costs in percentage terms than the US and China, analysis by accountancy firm UHY has shown, with Britain paying 0.5 per cent in duties on its imports in the 2017-18 financial year.
The UK government has unveiled an upgrade to its Accelerated Access Collaborative (ACC) initiative, aimed at creating a single ‘front door’ into the NHS for health innovation.
With digital transformation and regulation impacting the industry, healthcare companies are fighting to stay healthy amid market instability.
While you’re here…
…and are interested in our content, why not sign up to our newsletter?
It’s just below here.